C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/315.05, 260/
C07D 409/04 (2006.01) C07D 233/72 (2006.01) C07D 233/74 (2006.01) C07D 233/76 (2006.01) C07D 233/78 (2006.01)
Patent
CA 1122602
ABSTRACT Hydantoin compounds having the general formula (I): Image (I) in which at least one of R1, R2 and R3 is a group other than hydrogen and R1, R2 and R3 which may be the same or different are hydrogen, halogen, alkyl, hydroxyalkyl or a group of formula OR7 in which R7 is a hydrogen, alkyl or aralkyl and X is alkyl, thienyl or a group of general formula (II): Image (II) in which R4, R5 and R6 which may be the same or different are hy- drogen, halogen, alkyl, hydroxyalkyl or a group of formula OR7 (R7 having the same meaning as above, provided that at least one of R1, R2 and R3 is a group of formula OR7, and pharmaceutically accept- able salts of the compounds. These compounds are useful in the treatment of diseases caused by stress. Also described are pro- cesses for preparing them. Excluded from these novel compounds are 5-(4-hydroxyphenyl)-5-phenyl hydantoin; 5-(4-methoxyphenyl)- 5-phenyl-hydantoin; 5-5-bis(4-methoxyphenyl) hydantoin; and 5,5- bis(3,4-dimethoxyphenyl) hydantoin.
310821
Borden Ladner Gervais Llp
Nippon Zoki Pharmaceutical Co. Ltd.
LandOfFree
Hydantoin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydantoin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-915655